Large-scale testing (Phase 3)Ended earlyNCT04750278
What this trial is testing
Evaluate FP-025 in Patients With Severe to Critical COVID 19
Who this might be right for
Severe to Critical COVID 19 With Associated ARDS
Foresee Pharmaceuticals Co., Ltd. 90